Searching for genes in diabetes and the metabolic syndrome

International Journal of Clinical Practice, Supplement

Volumn , Issue 143, 2004, Pages 3-8

  Hitman, Graham A ^a   Sudagani, J ^a  

^a QUEEN MARY UNIVERSITY OF LONDON   (United Kingdom)

Author keywords

Diabetes; Genes; Metabolic syndrome

Indexed keywords

CALPAIN; GLUCOKINASE; HEPATOCYTE NUCLEAR FACTOR 4ALPHA; NUCLEAR FACTOR I; PEROXISOME PROLIFERATOR ACTIVATED RECEPTOR GAMMA; TRANSCRIPTION FACTOR;

CAPN10 GENE; CHROMOSOME 20; CONFERENCE PAPER; GENE; GENE ISOLATION; GENE MUTATION; GENETIC SUSCEPTIBILITY; HNF4ALPHA GENE; HUMAN; METABOLIC SYNDROME X; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; USF1 GENE;

CHROMOSOME MAPPING; DIABETES MELLITUS, TYPE 2; GENETIC PREDISPOSITION TO DISEASE; GLUCOKINASE; HUMANS; METABOLIC SYNDROME X; RECEPTORS, CYTOPLASMIC AND NUCLEAR;

EID: 10344261475     PISSN: 1368504X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (38)

1. Rich SS. Mapping genes in diabetes. Genetic epidemiological perspective. Diabetes 1990; 39 (11): 1315-9.
2. Lee KE, Klein BE, Klein R. Familial aggregation of components of the multiple metabolic syndrome in the Framingham Heart and Offspring Cohorts: Genetic Anal Workshop Problem 1. BMC Genet 2003; 4 (Suppl. 1): 94.
3. Mills GW, Avery PJ, McCarthy MI et al. Heritability estimates for beta cell function and features of the insulin resistance syndrome in UK families with an increased susceptibility to Type 2 diabetes. Diabetologia 2004; 47 (4): 732-8.
4. Freeman MS, Mansfield MW, Barrett JH, Grant PJ. Heritability of features of the insulin resistance syndrome in a community-based study of healthy families. Diabet Med 2002; 19 (12): 994-9.
5. Serjeantson SW, Owerbach D, Zimmet P et al. Genetics of diabetes in Nauru: effects of foreign admixture, HLA antigens and the insulin-gene-linked polymorphism. Diabetologia 1983; 25 (1): 13-7.
6. Medici F, Hawa M, Ianari A et al. Concordance rate for type II diabetes mellitus in monozygotic twins: actuarial analysis. Diabetologia 1999; 42 (2): 146-50.
7. Wiltshire S, Hattersley AT, Hitman GA et al. A genomewide scan for loci predisposing to type 2 diabetes in a U.K. population (the Diabetes UK Warren 2 Repository): analysis of 573 pedigrees provides independent replication of a susceptibility locus on chromosome 1q. Am J Hum Genet 2001; 69 (3): 553-69.
8. Gregor PD, Sawadogo M, Roeder RG. The adenovirus major late transcription factor USF is a member of the helix-loop-helix group of regulatory proteins and binds to DNA as a dimer. Genes Dev 1990; 4 (10): 1730-40.
9. Pajukanta P, Lilja HE, Sinsheimer JS et al. Familial combined hyperlipidemia is associated with upstream transcription factor 1 (USF1). Nat Genet 2004; 36 (4): 371-6.
10. Shieh BH, Sparkes RS, Gaynor RB, Lusis AJ. Localization of the gene-encoding upstream stimulatory factor (USF) to human chromosome 1q22-q23. Genomics 1993; 16 (1): 266-8.
11. Pajukanta P, Nuotio I, Terwilliger JD et al. Linkage of familial combined hyperlipidaemia to chromosome 1q21-q23. Nat Genet 1998; 18 (4): 369-73.
12. Das SK, Hasstedt SJ, Zhang Z, Elbein SC. Linkage and association mapping of a chromosome 1q21-q24 type 2 diabetes susceptibility locus in northern European Caucasians. Diabetes 2004; 53 (2): 492-9.
13. Xiang K, Wang Y, Zheng T et al. Genome-wide search for type 2 diabetes/impaired glucose homeostasis susceptibility genes in the Chinese: significant linkage to chromosome 6q21-q23 and chromosome 1q21-q24. Diabetes 2004; 53 (1): 228-34.
14. Johnson JD, Han Z, Otani K et al. RyR2 and calpain-10 delineate a novel apoptosis pathway in pancreatic islets. J Biol Chem 2004; 279 (23): 24794-802.
15. Sreenan SK, Zhou YP, Otani K et al. Calpains play a role in insulin secretion and action. Diabetes 2001; 50 (9): 2013-20.
16. Patel YM, Lane MD. Role of calpain in adipocyte differentiation. Proc Natl Acad Sci USA 1999; 96 (4): 1279-84.
17. Yajima Y, Kawashima S. Calpain function in the differentiation of mesenchymal stem cells. Biol Chem 2002; 383 (5): 757-64.
18. Hanis CL, Boerwinkle E, Chakraborty R et al. A genome-wide search for human non-insulin-dependent (type 2) diabetes genes reveals a major susceptibility locus on chromosome 2. Nat Genet 1996; 13 (2): 161-6.
19. Cox NJ, Frigge M, Nicolae DL et al. Loci on chromosomes 2 (NIDDM1) and 15 interact to increase susceptibility to diabetes in Mexican Americans. Nat Genet 1999; 21 (2): 213-5.
20. Horikawa Y, Oda N, Cox NJ et al. Genetic variation in the gene encoding calpain-10 is associated with type 2 diabetes mellitus. Nat Genet 2000; 26 (2): 163-75.
21. Weedon MN, Schwarz PE, Horikawa Y et al. Meta-analysis and a large association study confirm a role for calpain-10 variation in type 2 diabetes susceptibility. Am J Hum Genet 2003; 73 (6): 1208-12.
22. Song Y, Niu T, Manson JE et al. Are variants in the CAPN10 gene related to risk of type 2 diabetes? A quantitative assessment of population and family-based association studies. Am J Hum Genet 2004; 74 (2): 208-22.
23. Baier LJ, Permana PA, Yang X et al. A calpain-10 gene polymorphism is associated with reduced muscle mRNA levels and insulin resistance. J Clin Invest 2000; 106 (7): R69-R73.
24. Stoffel M, Duncan SA. The maturity-onset diabetes of the young (MODY1) transcription factor HNF4alpha regulates expression of genes required for glucose transport and metabolism. Proc Natl Acad Sci USA 1997; 94 (24): 13209-14.
25. Sander M, German MS. The beta cell transcription factors and development of the pancreas. J Mol Med 1997; 75 (5): 327-40.
26. Silander K, Mohlke KL, Scott LJ et al. Genetic variation near the hepatocyte nuclear factor-4 alpha gene predicts susceptibility to type 2 diabetes. Diabetes 2004; 53 (4): 1141-9.
27. Love-Gregory LD, Wasson J, Ma J et al. A common polymorphism in the upstream promoter region of the hepatocyte nuclear factor-4 alpha gene on chromosome 20q is associated with type 2 diabetes and appears to contribute to the evidence for linkage in an ashkenazi Jewish population. Diabetes 2004; 53 (4): 1134-40.
28. Auwerx J. PPARgamma, the ultimate thrifty gene. Diabetologia 1999; 42 (9): 1033-49.
29. Greene ME, Blumberg B, McBride OW et al. Isolation of the human peroxisome proliferator activated receptor gamma cDNA: expression in hematopoietic cells and chromosomal mapping. Gene Expr 1995; 4 (4-5): 281-99.
30. Altshuler D, Hirschhorn JN, Klannemark M et al. The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes. Nat Genet 2000; 26 (1): 76-80.
31. Luan J, Browne PO, Harding AH et al. Evidence for gene-nutrient interaction at the PPARgamma locus. Diabetes 2001; 50 (3): 686-9.
32. Lindi VI, Uusitupa MI, Lindstrom J et al. Association of the Pro12Ala polymorphism in the PPAR-gamma2 gene with 3-year incidence of type 2 diabetes and body weight change in the Finnish Diabetes Prevention Study. Diabetes 2002; 51 (8): 2581-6.
33. Ledermann HM. Maturity-onset diabetes of the young (MODY) at least ten times more common in Europe than previously assumed? Diabetologia 1995; 38 (12): 1482.
34. German MS. Glucose sensing in pancreatic islet beta cells: the key role of glucokinase and the glycolytic intermediates. Proc Natl Acad Sci USA 1993; 90 (5): 1781-5.
35. Hattersley AT, Turner RC, Permutt MA et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet 1992; 339 (8805): 1307-10.
36. Yamagata K, Oda N, Kaisaki PJ et al. Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature 1996; 384 (6608): 455-8.
37. Vaxillaire M, Boccio V, Philippi A et al. A gene for maturity onset diabetes of the young (MODY) maps to chromosome 12q. Nat Genet 1995; 9 (4): 418-23.
38. Pearson ER, Starkey BJ, Powell RJ et al. Genetic cause of hyperglycaemia and response to treatment in diabetes. Lancet 2003; 362 (9392): 1275-81.